SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001078782-20-000869
Filing Date
2020-11-16
Accepted
2020-11-16 15:52:00
Documents
8
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT f10q093020_10q.htm 10-Q 425847
2 EXHIBIT 10.4 INDEMNIFICATION AGREEMENT DATED NOVEMBER 1, 2020 WITH JAMES SAPIRST f10q093020_ex10z4.htm EX-10.4 46580
3 EXHIBIT 10.5 INDEMNIFICATION AGREEMENT DATED NOVEMBER 1, 2020 WITH TERRY BROSTOW f10q093020_ex10z5.htm EX-10.5 45902
4 EXHIBIT 10.6 INDEMNIFICATION AGREEMENT DATED NOVEMBER 1, 2020 WITH BRUCE HARMON f10q093020_ex10z6.htm EX-10.6 46591
5 EXHIBIT 31.1 SECTION 302 CERTIFICATION f10q093020_ex31z1.htm EX-31.1 8618
6 EXHIBIT 31.2 SECTION 302 CERTIFICATION f10q093020_ex31z2.htm EX-31.2 8612
7 EXHIBIT 32.1 SECTION 906 CERTIFICATION f10q093020_ex32z1.htm EX-32.1 3386
8 EXHIBIT 32.2 SECTION 906 CERTIFICATION f10q093020_ex32z2.htm EX-32.2 3384
  Complete submission text file 0001078782-20-000869.txt   590102
Mailing Address 225 CHIMNEY CORNER LANE, STE 2001 JUPITER FL 33458
Business Address 225 CHIMNEY CORNER LANE, STE 2001 JUPITER FL 33458 732-723-7395
MARIZYME INC (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53223 | Film No.: 201316439
SIC: 2834 Pharmaceutical Preparations